Expression Table for this CRE
| CNhs12060 | Skeletal Muscle Cells, donor6 | 6.8 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 5.4 |
| CNhs12229 | pituitary gland, adult, donor10252 | 4.5 |
| CNhs14600 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 3.0 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 2.8 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 2.8 |
| CNhs14416 | 293SLAM rinderpest infection, 24hr, biol_rep1 | 1.5 |
| CNhs14551 | thalamus, adult, donor10258 | 1.3 |
| CNhi10941_CAC | Human primary dermal lymphatic vascular endothelial cells, biol_rep2 | 1.1 |
| CNhs12055 | Fibroblast - Dermal, donor5 | 1.1 |
| CNhs12079 | Pericytes, donor2 | 1.1 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 1.0 |
| CNhs14489 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 1.0 |
| CNhs11741 | diffuse large B-cell lymphoma cell line:CTB-1 | 1.0 |
| CNhs14591 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 0.9 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 0.9 |
| CNhs12011 | Fibroblast - Aortic Adventitial, donor3 | 0.9 |
| CNhs13919 | CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 0.9 |
| CNhs14060 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 0.8 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 0.8 |
| CNhs14595 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 0.8 |
| CNhs14496 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 0.7 |
| CNhs14603 | Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 0.7 |
| CNhs14613 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 0.7 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 0.6 |
| CNhs13339 | Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1) | 0.6 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 0.6 |
| CNhs14582 | Myoblast differentiation to myotubes, day06, control donor3 | 0.6 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 0.6 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 0.6 |
| CNhs12044 | Smooth Muscle Cells - Carotid, donor3 | 0.5 |
| CNhs12652 | MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 0.5 |
| CNhs14486 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 0.5 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 0.5 |
| CNhs14534 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 0.5 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 0.4 |
| CNhs14556 | acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 0.4 |
| CNhs13361 | Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 0.4 |
| CNhs14471 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3 | 0.4 |
| CNhs14410 | 293SLAM rinderpest infection, 06hr, biol_rep1 | 0.4 |
| CNhs11893 | adrenal cortex adenocarcinoma cell line:SW-13 | 0.4 |
| CNhs13437 | cerebrospinal fluid, donor2 | 0.4 |
| CNhs12312 | hippocampus, adult, donor10252 | 0.4 |
| CNhs13376 | Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53) | 0.3 |
| CNhs14558 | Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 0.3 |
| CNhi10786_TAC | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep2 | 0.3 |
| CNhs14538 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 0.3 |
| CNhs12376 | mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 0.3 |
| CNhs12797 | K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 0.3 |
| CNhs14559 | Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 0.3 |